The triple agonist already maximally activated the relevant pathway
Factors such as adherence to the medication, individual metabolism, and lifestyle choices all influence the timeline for visible results
If you notice tasks like carrying groceries or climbing stairs becoming harder despite weight loss, it could signal muscle loss
A method for treating obesity in a subject in need thereof, wherein the subject in need of treatment is pediatric, comprising administering 1.25 mg once weekly tirzepatide, or a pharmaceutically acceptable salt thereof, to the subject for a minimum of four weeks
Compounded semaglutide available through Noom-GLP1 is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality
Accessed October 28, 2025.